Examining the feasibility and acceptability of a six-week at-home physical activity intervention with a focus on strength training for Black women: a randomized controlled trial
Abstract
Background: Physical activity (PA) is protective against many health conditions such as cardiovascular disease (CVD), obesity, and all-cause mortality. Black women have some of the highest rates of non-communicable diseases associated with a lack of PA. Most previous PA studies for Black women have focused on aerobic PA. This was one of the first studies to explore a PA program for Black women that emphasized strength training and utilized home-based methodology. The current pilot randomized controlled trial evaluated the feasibility and acceptability of an at-home strengthening physical activity intervention. The study also examined the preliminary efficacy of a physical activity intervention (PAI) on physical activity and psychosocial variables, compared to a wait-list-control (WLC) group.
Methods: Low-active Black women (< 90 min physical activity per week; n = 36; mean age = 44.0, + / 12.6) were randomized to either the six-week PAI or WLC. Participants in the PAI were sent workouts and demonstration videos weekly via email, engaged in a weekly group Zoom counseling and exercise session, and participated in a social media motivational group chat. Participants were assessed at baseline and at the conclusion of the six-week intervention. The primary outcomes of the current study are feasibility and acceptability as measured by retention and self-reported satisfaction via survey and focus groups. Additionally, descriptive statistics were obtained regarding physical activity…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 36 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.